Tuesday, Medtronic Plc (NYSE:MDT) reported second-quarter 2025 sales of $8.40 billion, beating the consensus of $8.27 billion ...

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.

Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future.

Oura recently introduced its fourth-generation smart ring, but now it’s focusing on a new partnership with another giant in ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

"DigiCoach program" is a pilot program by Singapore Health Promotion Board, Health2Sync, and Abbott that aims to help individuals with pre-diabetes or high BMI prevent or delay the onset of diabetes.

Smart ring maker Oura Health Oy is getting a $75 million investment from medical device firm Dexcom Inc., setting the stage for the two companies to share data and cross-sell products.

The Kilkenny, Ireland facility will focus on the global manufacturing of sensors for Abbott’s CGM diabetes devices.

American Diversified Holdings Corporation (ADHC) Retains Dr. Stephen C. Weber, MD, FACS As Head of Medical Advisory Board ...

Partnership will enable two-way data flow between Dexcom glucose biosensors and apps and Oura Ring and the Oura App, ...

Oura and glucose monitoring company Dexcom have formed an agreement to share data between apps, but the partnership goes even ...

Finland in 2013, makes a smart ring that helps customers track sleep, activity, stress and heart health among other features. Dexcom makes continuous glucose monitoring devices, including a ...